Launch sequencing of pharmaceuticals with multiple therapeutic indications: evidence from seven countries
New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear.
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
13 February 2023
|
| In: |
BMC health services research
Year: 2023, Jahrgang: 23, Pages: 1-17 |
| ISSN: | 1472-6963 |
| DOI: | 10.1186/s12913-023-09095-2 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12913-023-09095-2
|
| Verfasserangaben: | Mackenzie Mills, Daniel Michaeli, Aurelio Miracolo and Panos Kanavos |
| Zusammenfassung: | New medicines are increasingly being identified as efficacious across multiple indications. The impact of current pricing and reimbursement policies on launch decisions across these indications remains unclear. |
|---|---|
| Beschreibung: | Gesehen am 17.04.2023 |
| Beschreibung: | Online Resource |
| ISSN: | 1472-6963 |
| DOI: | 10.1186/s12913-023-09095-2 |